Table 3: Checklists for monitoring the efficacy and safety of TRT in men with LOH and functional hypogonadism.

Section and Topic

Checklist item

Location where item is reported

Project overview

 

 

 

Title

 

 

Protocol summary

 

 

 

Investigators/collaborators

 

Introduction

 

 

 

Rationale: describe the rationale for the LOH or FH study in the context of existing knowledge

 

 

Objective & Hypotheses: Provide an explicit of the objectives & hypotheses on the study on LOH or FH

 

 

Justification for the study

 

Method/Procedure

 

 

Design

How the study design will meet the objectives and address hypotheses

 

 

Study time line

 

 

Protocol review request

 

Study Population

Case definition for LOH and FH

 

 

Eligibility criteria: Should include inclusion and exclusion criteria for both participants and control for the study

 

 

 

 

 

Sample size, sampling and statistical power

 

 

Enrolment for the study

 

Interventions or variables

Study instruments including questionnaires, laboratory instruments and analytic test

 

 

Intervention or treatment to be given to LOH of FH, at what interval and duration?

 

 

Outcomes: Should include major adverse cardiovascular events as part of the primary outcome measures

 

Data handling and Analysis

Data collection

 

 

Data entry, editing and management including storage

 

 

Quality control and assurance

 

 

Bias in data collection, measurement and analysis

 

 

Limitation of study

 

Adverse Events or Unexpected Findings

Identify, managing and reporting of adverse events to interventions or placebo used in the study

 

 

Emergency care available

 

Notification, Reporting & Dissemination of Results

Notify participants of their individual results and study findings

 

 

Disseminate results on LOH and FH to the public

 

References

 

 

Appendix Material

Data collection form and other relevant documents

 

 

Tables and figures